Attached files

file filename
EX-99.1 - PRESS RELEASE - Brooklyn ImmunoTherapeutics, Inc.ntn_ex9901.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 28, 2012

 

 

NTN BUZZTIME, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

(State or Other Jurisdiction of Incorporation)

 

     
001-11460   31-1103425
(Commission File Number)  

(IRS Employer

Identification No.)

     

2231 Rutherford Road, Suite 200

Carlsbad, California

  92008
(Address of Principal Executive Offices)   (Zip Code)
     

 

(760) 438-7400

(Registrant's telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

1
 

 

Item 8.01. Other Events.

On February 28, 2012, we issued a press release announcing the final results of our rights offering. A copy of the press release is included as an exhibit to this report and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

99.1Press Release dated February 28, 2012

 

 

 

2
 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  NTN BUZZTIME, INC.
     
Dated: February 28, 2012 By: /s/ Kendra Berger
   

Kendra Berger

Chief Financial Officer

 

 

3
 

 

 

EXHIBIT INDEX

 

Exhibit No. Document                             
   
99.1 Press Release dated February 28, 2012

 

 

 

4